Grace-Marie Turner

Contributor

Grace-Marie Turner is president of the Galen Institute.

Follow on
gracemarietweet

LATEST

    • Opinion

    Medicare Drugs on Chopping Block

    Grace-Marie Turner
    The Biden administration is expected to announce, by Sept. 1, the first 10 prescription drugs it will target in its newly authorized drug price “negotiation” regime. Under the Inflation Reduction Act (more properly dubbed the Innovation Reduction Act), the Centers for Medicare and Medicaid Services will announce the 10 drugs under Medicare Part D that…
    View More
    • Opinion

    Democrats Use Accounting Gimmicks to Conceal Spending in Bloated ‘Build Back Better’ Bill

    Grace-Marie Turner
    • Opinion

    Democrats’ Destructive Spending Spree Would Turn America Into a European Social Welfare State

    Grace-Marie Turner
    • Opinion

    Too Big to Pass? Democrats Divided Over $3.5 Trillion Tax-and-Spend Behemoth

    Grace-Marie Turner
    • Opinion

    Democrats’ Drug Price Controls Threaten Biotech Research, Patients

    Grace-Marie Turner
    • Opinion

    The High Cost of Drug Price Controls

    Grace-Marie Turner
    • Opinion

    The New Push to Expand Government’s Role in Health Care Won’t Work. Here’s How We Can Help Americans Instead.

    Marie Fishpaw
    • Opinion

    What’s Needed for Health Care Reform: Personalized Care That Puts You and Your Doctor in Charge

    Marie Fishpaw
    • Opinion

    Responding to the Coronavirus Crisis and Building a Stronger Health Sector for the Future

    Marie Fishpaw
    • Opinion

    Here’s the Path Forward for Health Reform in 2018

    Marie Fishpaw
    • Opinion

    Americans Need Health Reform to Be a Priority Issue in 2018

    Rick Santorum